Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

NCT00184548 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

554

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description

Conditions

Acquired Bleeding Disorder
Trauma

Interventions

DRUG: eptacog alfa (activated)
DRUG: placebo

Sponsor

Novo Nordisk A/S